BNP PARIBAS ARBITRAGE, SA

Position in CGON — CG Oncology, Inc.

CIK 1166588 NEW YORK, NY

Position in CGON

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$7,312,079

+$3,321,883 QoQ

Shares Held

108,039

+12.4% QoQ

Ownership

0.122%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $2,946,330,584 across 411 Biotechnology names. CGON ranks #65 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	448,371	$346,429,369
2	MRNA	Moderna, Inc.	4,317,219	$219,314,725
3	VRTX	Vertex Pharmaceuticals Inc / Ma	415,625	$185,593,187
4	BNTX	BioNTech SE	1,651,789	$146,811,006
5	ARGX	Argenx SE	177,836	$129,864,739
6	INSM	INSMED Inc	604,600	$98,864,192
7	BBIO	BridgeBio Pharma, Inc.	1,307,176	$97,070,889
8	ALNY	Alnylam Pharmaceuticals, Inc.	280,965	$92,962,889

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,312,079	108,039	+12.4%	Shares	Defined	2026-05-12
2025-12-31	$3,990,196	96,103	+723.2%	Shares	Defined	2026-02-10
2025-09-30	$470,269	11,675	-85.3%	Shares	Defined	2025-11-13
2025-06-30	$2,071,160	79,660	+2008.0%	Shares	Defined	2025-08-14
2025-03-31	$92,547	3,779	-32.9%	Shares	Defined	2025-05-14
2024-12-31	$161,640	5,636	-78.9%	Shares	Defined	2025-02-14
2024-09-30	$1,005,881	26,660	+876.9%	Shares	Defined	2024-11-13
2024-06-30	$86,154	2,729	-75.6%	Shares	Defined	2024-08-13
2024-03-31	$491,592	11,198	—	Shares	Defined	2024-05-01
No filing history on record for this holder in this stock.